Mobile Motivational Messages for Change (3M4Chan) Intervention in TMU

Taipei Medical University

Status: Completed

Conditions: Explore Successful Method to Quit Smoking

Treatments: Other: Case

Study type: Interventional

Funder types: Other

Identifiers

NCT03108651

N201702069

Details and patient eligibility

About

About 100 (50 from TMU Hospital and 50 from Wellcome Clinic) current smokers will be recruited who contact smoke cession clinics in teaching hospitals of Taipei Medical University (TMU) and Wellcome Clinic. They will be randomly assigned either to Usual Care (UC) or Usual Care plus 3M4Chan Intervention group (IG). A randomized comparative effectiveness trial will be conducted. Patient will enroll from September 2017 to May 2018. In UC group, the physician provides a brief advice to quit during first consultation, a quit plan template, and medication prescription (Varenicline, Bupropion, Champix, Nicotinell TTS20) as decided by the physician. IG group includes UC plus a mobile App that is programmed to push tailored messages for health concern and readiness to quit, tips for sustaining abstinence, use of interactive self-assessments, helpful cessation information. This group of smokers will benefit from tailored cessation interventions with integrated body weight management elements that take into consideration the prevailing local and cultural influences on diet and levels of physical activity. IG will be continued even after stopping of the UC.

Enrollment: 92 patients

Sex: All

Ages: 20+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Age 20 years or older and approach smoke cessation clinic at TMU hospital
• Have an Android mobile phone
• Able to read Traditional Chinese
• Willing to participate in all study components
• Willing to be followed-up for 6 months
• Smoked at least once every month in the last two years
• Current smoker

Exclusion criteria

• • Below 20 years on the day of enrolment

  • Not willing to participate in the study
  • Those who do not have Android mobile phone or unable to read Mandarin
  • Not willing to share medical information from EHR
  • Subjects who develop adverse effects related to the pharmacological treatment included in the study

Trial design

Primary purpose: Supportive Care

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

92 participants in 2 patient groups

Case

Active Comparator group

Description:

Motivational message will be administrated.

Treatment:

Other: Case

Control

No Intervention group

Description:

Motivational message will not be administrated.